YARW
Yarrow Bioscience Inc
22.50$
-6.9%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -33.3% | +28.9% | +102.0% | -38.9% | -30.6% | +140.5% | -65.8% | +144.9% | -23.1% | -33.8% | +12.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | +0.0% | – | |
| – | -33.3% | +28.9% | +102.0% | -38.9% | -30.6% | +140.5% | -65.8% | +144.9% | -23.1% | -38.5% | +13.7% | – | |
| – | -8.9% | +22.7% | +97.0% | +40.3% | -5.5% | -36.8% | -20.3% | +7.7% | -43.4% | -72.6% | -3.5% | – | |
| – | – | – | -12.8% | -9.9% | +7.0% | +3.3% | -16.6% | -0.9% | -12.3% | +29.8% | -21.7% | – | |
| – | +8.8% | +8.3% | +41.7% | +24.7% | -2.7% | -26.9% | -19.0% | +4.6% | -32.8% | -27.2% | -18.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.